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ABSTRACT 
Reporter genes, such as luciferase and green fluorescent protein (GFP), have 
simplified efforts to study transcriptional regulatory elements, tag endogenous 
proteins, and label and track individual cells in vivo. While these reporters 
represent a major advance in cellular imaging they have significant limitations. 
Luciferase, GFP and other reporter genes are restricted by a high cellular energy 
requirement for their synthesis and a long lag time between the initiation of 
transcription and reporter protein expression. Also, the method for study of 
endogenous RNAs utilizing reporter genes is quite complex and limited. 
RNA reporters could allow determination of rapid changes in gene 
expression and may also be used as a tag to make RNA fusion constructs to 
track other RNAs in vivo. As there is no known naturally produced RNA with 
inherent fluorescence sufficient for imaging, our approach has been to use RNA 
aptamers to bind a target molecule with a fluorescent or radioactive label. 
Aptamers, single stranded RNA or DNA molecules, have high binding affinity and 
specificity, low molecular mass, and have been selected to recognize enzymes, 
receptors, growth factors and small molecules. 
This work describes part of an effort to develop an RNA tag and reporter 
gene using the RNA aptamer for theophylline. For the tag to be successful in 
vivo, the ligand cannot be a natural component of the cell. Theophylline and its 
aptamer were chosen because theophylline is a small molecule drug and its 
aptamer has proven functional in bacteria, yeast and cultured human cells. 
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The proposed IMAGEtag (intracellular multi aptamer genetic tag) will 
consist of a string of multiple tandem aptamers that can be expressed in cells as 
RNAs. Multiaptamers were constructed in order to increase the binding capacity 
of the IMAGEtags. Initially, short multiaptamers were cloned using synthetic 
oligonucleotides. Elongated multiaptamers were constructed utilizing a modified 
recursive directional ligation (RDL) technique that employs the non palindromic 
restriction enzymes BsaI and BsmAI. The multiaptamers were cloned into a 
mammalian expression vector containing a β-actin promoter and CMV enhancer 
and expressed in CCL64 cells. Expression and stability of the IMAGEtags were 
analyzed by real time reverse transcription PCR. The ligands for this IMAGEtag 
were radioactive theophylline-[3H] and GK38, a theophylline analog labeled with 
the fluorescent molecule rhodamine-B. GK38 was examined utilizing assays for 
cellular efflux and localization. Efflux assays were also performed with 
rhodamine-B, and theophylline-[3H]. Theophylline-[3H] was used to investigate 
whether IMAGEtag expression had an effect on the cellular concentration of 
theophylline. 
Cloning of a theophylline multiaptamer using synthetic oligonucleotides 
resulted in a construct with six aptamer repeats, which was used to create 
constructs with 18, 90 and 270 repeats by the RDL technique. Expression of the 
18 repeat multiaptamer in CCL64 cells resulted in a maximum RNA level 24 
hours after transfection, and the RNA was determined to have high stability with 
an approximate half-life of 43 hours. Using a rhodamine-theophylline conjugate 
to track theophylline in the cells revealed that it binds to endogenous cellular 
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components localized mainly in the Golgi apparatus. Efflux assays showed that 
55-60% of the conjugate remains bound to the cells after 1 hour, compared to 
30-40% for rhodamine-B and 60-80% for theophylline. It was determined that 
expression of the theophylline IMAGEtag did not have any effect on the cellular 
concentration of theophylline. However, it was not determined if the tandemly 
linked theophylline aptamers in this RNA were capable of binding theophylline. 
The observed binding of theophylline and rhodamine-theophylline to 
cellular components creates a high background signal that obscures a potential 
signal from the IMAGEtag. This could limit the effectiveness of a reporter system 
based on theophylline and the theophylline aptamer, and other aptamers and 
ligands may be more suitable for use as reporters. Alternatively, utilizing Förster 
resonance energy transfer (FRET), a pair of fluorescently labeled aptamer 
ligands could generate a unique signal when binding to adjacent aptamers in an 
IMAGEtag. 
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CHAPTER 1. GENERAL INTRODUCTION 
This work was part of an effort to develop an RNA tag and reporter gene 
using the RNA aptamer for theophylline. An RNA reporter could provide a more 
direct measure of transcriptional activity than enzyme based reporter genes, and 
potentially allow determination of rapid changes in gene expression. Additionally, 
the RNA reporter may also be used as a tag to make RNA fusion constructs, to 
track other RNAs in the cell and organism, in much the same way as fluorescent 
proteins have been used to study other proteins. Since there is no known 
naturally produced RNA with inherent fluorescence sufficient for imaging, our 
approach has been to use RNA aptamers that can bind to a target molecule with 
a fluorescent label. My colleagues, PhD candidates, Ilchung Shin and Muslum 
Ilgu, also participated in this project with their focus being on aptamers against 
aminoglycoside antibiotics (kanamycin, tobramycin and neomycin). 
Current reporter genes 
Reporter genes were developed as tools to study transcriptional regulatory 
elements, namely promoters and enhancers. To determine the activity of a 
promoter, a vector is created in which the promoter is placed upstream of the 
reporter gene to regulate its expression. The reporter gene product could be 
easily detected and quantified. The transcriptional activity of the promoter could 
then be estimated based on the amount of reporter gene product. Vectors that 
express reporter genes from a constitutive promoter could also be used to 
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determine the efficiency of transfection or other gene delivery methods (Alam 
and Cook, 1990). 
 Early reporter genes include chloramphenicol acetyltransferase (CAT,) 
luciferase, human growth hormone (hGH), alkaline phosphatase and 
β-galactosidase. hGH is secreted from the cells and can be detected by 
radioimmunologic assay of the culture medium. The rest are enzymes and would 
be assayed based on their activity, usually by lysing and extracting the 
components of the cells. β-galactosidase and luciferase can also be analyzed in 
situ, to identify specific cells that express these enzymes. CAT was initially the 
most used reporter gene, but has for the most part been replaced by luciferase 
(Alam and Cook, 1990) 
 Luciferase from the firefly Photinus pyralis catalyzes the ATP driven 
oxidative decarboxylation of firefly luciferin, resulting in the emission of a photon 
of light. Firefly luciferase can be quantified by measuring the emission of light 
with a luminometer. It gained popularity because the luciferase assay is simpler 
and yields higher sensitivity (30- to 1000-fold) compared to CAT (de Wet et al., 
1987; Alam and Cook, 1990).  
 The availability of reporter genes has simplified efforts to quantify the 
activity of transcriptional regulatory elements. Reporter genes have also been 
valuable in studies to determine the efficiency of gene delivery methods. The 
application of reporter genes has expanded to imaging of cells, as well as 
intracellular components, with the discovery of fluorescent proteins. 
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Fluorescent proteins 
Fluorescent proteins (FP) do not require a substrate, and their fluorescence can 
be detected in living cells. Fluorescent microscopy enables researchers to study 
changes in expression in specific cells, and determine the intracellular location of 
the FP. The locations, movements and interactions of proteins have been 
elucidated by generating FP fusion proteins. FPs with different colors can be 
used to study several processes simultaneously, and certain pairs of FPs can be 
used in Förster resonance energy transfer (FRET) experiments to study 
interactions between different proteins (Chudakov et al., 2005; Shaner et al., 
2005). 
Green fluorescent protein (GFP) was discovered in 1962 during isolation 
of the bioluminescent protein aequorin from the jellyfish Aequoria victoria 
(Shimomura et al., 1962). Aequorin emits blue light (470 nm), while the intact 
organism emits green light (509 nm). It was demonstrated that the luminescence 
from aequorin is transferred to GFP, which emits green light. GFP has a maximal 
excitation at 400 nm with a second small peak at 480 nm. Its emission maximum 
is 508-509 nm, and the quantum yield is 0.72 when excited at 470 nm (Morise et 
al., 1974).  
Development of GFP as a reporter gene began with the cloning and 
sequencing of the GFP gene and cDNA in 1992. The cDNA encodes a 238 
amino acid protein with a calculated molecular weight of 26.9 kDa (Prasher et al., 
1992). The first report of expression of functional GFP in cells other than 
A. victoria was published two years later in 1994. GFP expressed in Escherichia 
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coli and Caenorhabditis elegans displayed identical fluorescence properties to 
natively expressed GFP (Chalfie et al., 1994). The chromophore (p-
hydroxybenzylidene-imidazolidinone) is formed spontaneously by cyclization and 
dehydrogenation from the three amino acids Ser65-Tyr66-Gly67 in the GFP 
polypeptide (Cody et al., 1993; Heim et al., 1994). 
 Much work has been done to improve and modify certain properties of 
GFP, such as the efficiency of folding and chromophore formation, exogenous 
expression levels, fluorescence intensity and the wavelengths of excitation and 
emission. Variants of GFP were created by inducing random mutations of the 20 
amino acids in and around the chromophore. These mutants were expressed in 
E. coli. Mutants with improved excitation at 488 nm, for use with the 488 nm 
argon laser and fluorescein-isothiocyanate (FITC) filters, were selected by 
fluorescence-activated cell sorting (FACS). One mutant (GFPmutl; F64L, S65T) 
exhibited a 35-fold increase in fluorescence, when excited at 488 nm. This 
mutant also displayed improved folding, resulting in an approximately 100-fold 
increase in fluorescence in E. coli 1 hour after induction of FP expression 
(Cormack et al., 1996). Based on this mutant, enhanced green fluorescent 
protein (eGFP) was developed by a group at Clontech introducing silent 
mutations to optimize for preferred human codons. This resulted in a 4-fold 
increase in expression of eGFP in human cells compared to GFPmutl (Yang et 
al., 1996; Zhang et al., 1996). 
 Similar mutation and screening experiments have been used to develop 
color variants of GFP such as cyan (eCFP) and yellow (YFP) fluorescent proteins 
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(Heim and Tsien, 1996; Miyawaki et al., 1997). The brightness of eCFP was 
relatively low (33% of GFP), but the improved variant Cerulean has a 2.5-fold 
increase in brightness compared to eCFP, as well as improved resistance to 
photobleaching (Rizzo et al., 2004). Improved variants of YFP, such as Citrine 
and Venus, were developed to decrease sensitivity to pH and chloride ions, 
which were the main problem with the original YFP (Nagai et al., 1989; Griesbeck 
et al., 2001). Blue fluorescent proteins (BFP) have also been developed from 
GFP, but they have not been commonly used due to low brightness and very low 
resistance to photobleaching. These properties have been improved in newer 
forms of BFP such as Azurite (Mena et al., 2006). 
Six additional fluorescent proteins were discovered in a variety of 
nonbioluminescent anthozoa species, including DsRed, a tetrameric red 
fluorescent protein from Discosoma striata (Matz et al., 1999). Mutation and 
selection of DsRed were used to decrease the maturation half-time from 24 
hours to less than 1 hour, and eliminate the partial green fluorescence exhibited 
by the original protein (Bevis and Glick, 2002). Additional modifications were 
made to disrupt oligomerization, and generate the monomer mRFP1 (Campbell 
et al., 2002).  Mutations of the mRFP1 sequence were made to create a number 
of fluorescent proteins in the orange to far red spectrum, notably mOrange, 
tdTomato, mCherry (Shaner et al., 2004) and mPlum (Wang et al., 2004). 
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In Vivo Imaging 
Several gene reporter systems have been developed for noninvasive imaging 
in vivo in order to determine the location and level of gene expression. Potential 
reporter systems have been explored using various imaging modalities including 
bioluminescence, fluorescence and radioactivity (Tsien, 2003). 
 Firefly luciferase has been a popular reporter gene because its 
bioluminescence is sufficient to detect fewer than a hundred cells. The long 
wavelength light (>600 nm) can penetrate through several mm of tissue, although 
increasing depth leads to both a weaker signal and lower resolution due to 
scattered photons (Tsien, 2003). For fluorescent proteins, the limited penetration 
of light through tissues is a challenge for both excitation as well as detection of 
emission. However, recent advances in optical imaging technology have greatly 
enhanced the utility of bioluminescent and fluorescent reporters in vivo. Detection 
of bioluminescence in vivo is significantly improved by the use of charge coupled 
device (CCD) cameras that are cooled to -120°C. The in creased sensitivity and 
signal-to-noise ratio of CCD cameras makes it possible to detect luciferase 
activity in deeper tissues (Contag and Bachmann, 2002). Although 
bioluminescent imaging does not provide high resolution, advances in fluorescent 
microscopy make it possible to image fluorescence at single cell resolution within 
tissues (Mempel et al., 2004). Recently, bimodal reporter systems utilizing both 
bioluminescence and fluorescence were used to study human neural stem cells 
(hNSCs) and glioma cells implanted into the brains of mice. This system provides 
the possibility for both real time imaging of global cell survival and migration 
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using bioluminescence, as well as determining the fates of implanted cells at 
single cell resolution using fluorescent proteins (Shah et al., 2008).  
Two imaging methods that utilize radioactive isotope labeled tracers have 
been widely used in humans for medical purposes (e.g. detecting tumors). Single 
photon emission computed tomography (SPECT) and positron emission 
tomography (PET) are used to detect isotopes that emit gamma rays and 
positrons respectively. Utilizing SPECT, gamma rays can penetrate through 
tissue and be detected directly by a gamma camera which is rotated around the 
subject to create three dimensional images. Positrons do not penetrate through 
the tissue, but instead collide with electrons and undergo annihilation, which 
causes two gamma rays to be emitted at close to 180 degrees. The simultaneous 
detection of two gamma rays is used to localize the tracer and generate the 
tomograpic image in a PET scan. Differences in the underlying principles, 
equipment and isotopes used in PET and SPECT, give each method certain 
limitations and advantages. The major advantage of PET is that it has over ten 
times the sensitivity of SPECT. Additionally, the positron emitting isotopes used 
in PET, such as 11C, 13N, 15O and 18F, can be used to substitute atoms or groups 
in organic molecules. However, different isotopes cannot be distinguished with 
PET because the gamma rays created from positron annihilations have the same 
energy (511 keV). Gamma rays emitted directly from atomic nuclei can have a 
range of energies, and dual-isotope SPECT can be used to image several 
isotopes simultaneously provided that the energies of their gamma rays are 
sufficiently different (Gambhir, 2002). 
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Intracellular enzymes, cell surface receptors or membrane transporters 
can serve as reporter genes for PET or SPECT. A popular PET reporter is the 
herpes simplex virus 1 thymidine kinase (HSV1-tk), which can trap thymidine 
analogs such as 18F-fluoroganciclovir (FGCV) inside cells by phosphorylation 
(Gambhir et al., 1999). The dopamine type 2 receptor (D2R) has been used as a 
PET reporter with the ligand 18F-fluoroethylspiperone (FESP) (MacLaren et al., 
1999). Membrane transporters can accumulate a tracer by pumping it into the 
cell. The sodium-iodide symporter has recently been used to image 
cardiac-derived stem cells implanted into the rat heart. The tracers 124I and 99mTc 
were used for PET and SPECT imaging, respectively (Terrovitis et al., 2008). 
RNA Imaging 
There have been important developments in protein imaging, but currently 
available methods for detecting and imaging RNA have significant limitations. 
Nucleic acids can be detected and imaged using fluorescent in situ hybridization 
(FISH). FISH utilizes fluorescently labeled nucleic acid probes that are 
complementary to the target RNA or DNA sequence. FISH has been used mainly 
in applications where the target is DNA, such as localizing a specific sequence 
on chromosomes (Volpi and Bridger, 2008). However, FISH can also be utilized 
to study mRNA expression (Femino et al., 1998) and cellular distribution 
(Guzowski et al., 2001). Although FISH is very useful for identification and 
localization of specific mRNA species, this technique requires that the cells or 
tissues to be studied are fixed. 
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 A method of tracking RNA in living cells was developed by labeling an 
mRNA with six repeats of a 19-nucleotide RNA stem loop, which serve as targets 
for the RNA binding protein MS2. The labeled RNA could then be detected by 
binding to MS2-GFP fusion proteins (Bertrand et al., 1998). The disadvantage of 
this method is that the MS2-GFP protein has to be expressed simultaneously 
with the labeled RNA. The fluorescent signal of GFP is always present and is 
redistributed upon binding to the RNA. Additionally, the extra RNA sequence and 
multiple MS2-GFP fusion proteins give the tag a mass of approximately 270kDa, 
which could have significant effects on the movement and function of the RNA 
(Tsien, 2003). 
Aptamers 
In 1990, two groups independently developed an in vitro selection method for 
generating synthetic oligonucleotides that could bind with high affinity and 
specificity to chosen target molecules. Ellington and Szostak selected RNA 
sequences that could bind to 7 different dyes, and named them aptamers after 
aptus, a Latin word meaning “to fit” (Ellington and Szostak, 1990). Concurrently, 
Tuerk and Gold developed an RNA aptamer for T4 DNA polymerase and coined 
the term SELEX (Systematic Evolution of Ligands by EXponential enrichment) for 
the selection process (Tuerk and Gold, 1990).  
The SELEX procedure starts with a pool of synthetic oligonucleotides 
consisting of a sequence of random nucleotides flanked by a constant primer 
binding sequence at both ends. Oligonucleotides in the pool are selected for 
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binding to a molecule of interest by incubation with an immobilized form of the 
target molecule followed by washing to remove non binding sequences and 
retrieval of binding sequences by elution with the target molecule. The bound 
fraction is amplified by PCR under low fidelity conditions so that some additional 
variability is introduced in the amplified product. Repeating the selection and 
amplification steps exponentially enriches the pool for binding sequences. 
Individual sequences are cloned and sequenced, and a number of sequences 
are analyzed to determine possible consensus sequences (Ellington and 
Szostak, 1990; Tuerk and Gold, 1990).  
Aptamer structure and stabilization 
Aptamers, which are composed of nucleic acids, form a variety of intricate 
structures. Stem loops are common feature of many aptamer structures. 
Mismatched bases within aptamer stem loops, often composed of pairs of 
purines, form binding pockets for small molecule ligands. Base stacking 
stabilizes the interaction between RNA aptamers and ligands by hydrophobic 
interactions and hydrogen bonding (Patel and Suri, 2000). 
RNA is sensitive to both enzymatic and non-enzymatic degradation. The 
original hairpin loop of the theophylline aptamer was found to be susceptible to 
cleavage catalyzed by Mg2+ in solution (Zimmermann et al., 2000). This 
degradation was abolished by replacing the original loop with a GAAA tetraloop, 
which is a common feature of many natural RNAs (Heus and Pardi, 1991). 
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 Additional stabilization is required for in vivo use, particularly if the 
application is extracellular. Several modifications are used to stabilize nucleic 
acids and make them more resistant to degradation by nucleases. Modified 
bases such as 2'-fluoro- and 2'-amino- pyrimidines were used to stabilize the 
hammerhead ribozyme (Pieken et al., 1991). An aptamer for HIV Type-1 
nucleocapsid protein was protected from degradation by linking the ends 
together to make it circular (Kim et al., 2002). Mirror image aptamers selected for 
D-adenosine (Klussmann et al., 1996) and L-arginine (Nolte et al., 1996) display 
much higher stability in vivo than their natural counterparts. Locked nucleic acids 
(LNA) exhibit higher melting temperatures than RNA or DNA, and an RNA 
aptamer modified as an LNA was also resistant to nucleases (Schmidt et al., 
2004). 
Applications of aptamers 
Aptamers have gained interest as potential therapeutics due to their high binding 
affinities and specificities (comparable to antibodies) yet low molecular mass (a 
40 nucleotide RNA would have a mass of approximately 13kDa). Aptamers have 
been selected against enzymes, receptors, growth factors, prions, toxins and 
viral capsule proteins (Gopinath, 2007).  
A 2'-F-pyrimidine aptamer was selected against vascular endothelial 
growth factor (VEGF). This aptamer binds with very high affinity to the isoform 
VEGF165 (KD 49 and 130 pM), but does not bind to isoform VEGF121 (Ruckman et 
al., 1998). Pegaptanib, a version of the VEGF aptamer conjugated to 
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polyethylene glycol (PEG), was approved for the treatment of age related 
macular degeneration by the FDA in 2004 (Kourlas and Schiller, 2006). 
Many aptamers have also been selected against small organic molecules. 
Molecules that bind to the ribosome and other cellular RNAs have been 
especially popular targets for aptamer selection. There are aptamers for a large 
number of antibiotics including tetracycline, chloramphenicol, viomycin, 
lividomycin, and several aminoglycosides (kanamycin, tobramycin, neomycin, 
streptomycin). Other targets include theophylline, dopamine, several nucleotides, 
amino acids, and cofactors. The structures of many aptamer small molecule 
complexes have been determined by NMR spectroscopy (Famulok, 1999; Patel 
and Suri, 2000). Aptamers have been used to develop biosensors for several 
drugs and other small molecules, including theophylline (Rankin et al., 2006; 
Ferapontova et al., 2008), adenosine (Lu et al., 2008) and cocaine (Baker et al., 
2006). Others aptamers have been used to control gene expression in vivo 
(Weigand and Suess, 2007; Tuleuova et al., 2008). 
Riboswitches - natural RNAs with aptamer-like properties 
More recently, it has been discovered that many RNAs with properties similar to 
aptamers occur naturally in bacteria and some eukaryotes. The majority of these 
are riboswitches that are often present in mRNAs and are involved in the 
regulation of translation. A thiamine (vitamin B1) riboswitch was found in an 
mRNA in E. coli. The mRNA encodes an enzyme involved in the biosynthesis of 
thiamine, and binding of thiamine to the riboswitch inhibits ribosome binding and 
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translation. Thus the riboswitch is responsible for feedback inhibition and limits 
the synthesis of the enzyme when the concentration of thiamine is sufficient 
(Winkler et al., 2002a). A similar feedback mechanism involving the biosynthesis 
of flavin mononucleotide (FMN, vitamin B2) was found in Bacillus subtilis. 
Although the FMN riboswitch was present in an mRNA, the mechanism of 
inhibition seems to involve premature transcriptional termination rather than 
translational inhibition (Winkler et al., 2002b). 
Application of aptamers for imaging  
There have been several attempts to develop RNA tags based on aptamers. The 
first aptamers were selected for the fluorophores sulforhodamine B and 
fluorescein with the goal of sequestering the respective fluorophores (Holeman et 
al., 1998). It was then found that an aptamer for malachite green can induce 
structural changes in its ligand. Malachite green is not fluorescent on its own, but 
becomes fluorescent upon binding to its aptamer (Babendure et al., 2003). 
Several aptamers have recently been developed against different dyes in 
attempts to make aptamer dye pairs that become fluorescent when they 
associate (Sparano and Koide, 2007; Constantin et al., 2008; Sando et al., 
2008). There has not yet been any demonstration of successful application of 
any RNA tag in living cells. 
Sulforhodamine-B and fluorescein aptamers 
Aptamers were selected for two commonly used fluorescent molecules 
sulforhodamine B and fluorescein. The selection process was performed using a 
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buffer with intracellular ion concentrations (100 mM K+, 10 mM Na+, 5 mM Mg2+). 
The sulforhodamine binding aptamer was selected from a pool of 
oligonucleotides with a random sequence of 72 nucleotides. An initial sequence 
was determined after seven rounds of selection for binding to sulforhodamine 
agarose. The last step included an elution with fluorescein to select against any 
RNA that was not specific for sulforhodamine. A 54 nucleotide truncated form of 
the aptamer was specific for sulforhodamine, and a KD of 310 ± 60 nM was 
determined by fluorescence anisotropy. An aptamer for fluorescein was selected 
from a doped pool of RNA based on the sulforhodamine aptamer (Holeman et 
al., 1998).  
  The fluorescein and sulforhodamine aptamers were biotinylated and 
bound to separate streptavidin beads. The labeled beads were able to 
concentrate their respective ligands in a solution containing 100 nM 
sulforhodamine and 125 nM fluorescein. The authors of this work discuss the 
possibility of using the aptamers to label RNA transcripts, and to measure the 
proximity between different aptamers by FRET (Holeman et al., 1998).  There 
has not been any report of further progress using these aptamers. 
Fluorescence switches and “Light-up” aptamers 
An aptamer for the dye malachite green (MG) was found to influence the 
fluorescent properties of its ligand. MG has a very low fluorescence when it is 
free in solution, but binding to the MG aptamer increased the quantum yield by 
2360-fold (binding also shifts the maximum absorbance from 618 nm to 630 nm). 
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The quantum yield of bound MG is 0.187, which is still low compared to most 
commonly used fluorophores. To improve fluorescence, an indolinyl derivative 
(IMG) with higher unbound quantum yield than MG was tested. IMG exhibited a 
similar enhancement of fluorescence (2090-fold), and the bound form of IMG has 
a quantum yield of 0.324 (Babendure et al., 2003). 
Sparano and Koide developed an RNA sensor by conjugating 
dichlorofluorescein (DCF) with two aniline moieties. Aniline is able to quench the 
fluorescence of DCF by photoinduced electron transfer (PET). When a 
fluorescent molecule is excited by absorption of light, an electron jumps from the 
highest occupied molecular orbital (HOMO) to the lowest unoccupied molecular 
orbital (LUMO). When the excited electron returns to the HOMO, the extra 
energy is released as a photon. PET occurs when an adjacent molecule 
(quencher) has a HOMO energy level between the HOMO and LUMO levels of 
the fluorophore. An electron can then jump from the HOMO of the quencher to 
the HOMO of the excited fluorophore, which results in quenching by hindering 
the excited electron in the LUMO to return to the HOMO. The efficiency of PET 
depends on the energy level of the HOMO of the quencher and the distance 
between quencher and fluorophore. In an attempt to control PET efficiency, an 
aptamer was developed for the aniline quencher. One aptamer was found to 
increase the fluorescence of the DCF-aniline conjugate by 13-fold at 100 µM. 
This demonstrates that an aptamer could be developed to control fluorescence 
by means of PET, but it has some limitations. The selected aptamer was over 
100 nucleotides long, and its binding affinity was not reported, although high 
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concentrations of aptamer (> 10 µM) are required to affect fluorescence 
(Sparano and Koide, 2007). 
Other RNA sensing probes have been developed based on fluorophores 
that are known to have fluorescent properties that change depending on their 
molecular interactions. The DNA stain Hoechst 33258 binds to AT rich regions of 
double stranded DNA (dsDNA), whereby its fluorescence is increased. A number 
of derivatives were tested for binding to dsDNA, and addition of two t-butyl 
groups was found to abolish its binding to dsDNA. A DNA aptamer was then 
selected for this derivative and binding to the aptamer resulted in a 191-fold 
increase in fluorescence (Sando et al., 2007). RNA aptamers were then selected 
for the same compound in an attempt to make a ‘blue fluorescent RNA’. A 29 
nucleotide aptamer was able to enhance the fluorescence of the modified 
Hoechst by 56-fold (to a quantum yield of 0.26) at a concentration of 200 nM. To 
test its function, the aptamer was incorporated into a construct to produce a 
tagged luciferase mRNA. The fluorescence of the dye increased during in vitro 
transcription of the tagged mRNA but not with untagged mRNA (Sando et al., 
2008). 
A similar approach was used to develop probes based on a modified 
cyanine dye. Dimethyl indole red (DIR) is a modified cyanine dye, with reduced 
affinity for DNA. A bulky dimethyl indole group and a sulphonate group were 
intended to interfere with intercalation and provide repulsion from anionic 
phosphate groups of nucleic acids respectively. An aptamer selected for DIR was 
shown to increase its fluorescence by 60-fold while DNA and non specific RNA 
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resulted in a 2-fold increase. The actual quantum yields for either free or bound 
dye were not reported (Constantin et al., 2008). 
Theophylline aptamer for imaging 
Although there are numerous small molecule aptamers available that could be 
used to make an RNA tag, there are certain considerations that have to be taken 
into account regarding both the aptamer and its ligand. For the tag to eventually 
be successful in vivo, the ligand cannot be a natural component of the cell. 
Otherwise, the endogenous ligand would compete for aptamer binding, and 
reduce its capacity to bind to the labeled (fluorescent or radioactive) ligand. This 
excludes the amino acids and vitamin/cofactors. Additionally, the ligand should 
not be toxic at concentrations used for imaging. The aptamer should have high 
affinity and selectivity, and function in the intracellular environment.  
Theophylline and its aptamer were chosen because theophylline is used 
as a drug, and the concentrations expected to be suitable for imaging are well 
below typically therapeutic doses. Theophylline also diffuses through the blood 
brain barrier, so the system could potentially be used in the brain. The 
theophylline aptamer has a reasonable affinity, and very high specificity for 
theophylline compared to similar compounds such as caffeine. The theophylline 
aptamer has also been demonstrated to function inside of cells. 
Theophylline 
Theophylline is a methylxanthine related to caffeine that has been used as a 
bronchodilator to treat asthma and COPD (chronic obstructive pulmonary 
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disease). The mechanism underlying the therapeutic effect of theophylline has 
not been completely determined. Theophylline is a known adenosine receptor 
antagonist and a phosphodiesterase (PDE) inhibitor, but it has been suggested 
that it may have other targets. It can increase the intracellular concentration of 
cyclic nucleotides (cAMP and cGMP) by inhibition of PDE. This was thought to 
be the main cause of its bronchodilatory effect, but it has been shown that PDE 
function is reduced by merely 5-20% at the therapeutic plasma concentration of 
10-20 mg/l (55-110 µM) (Barnes and Pauwels, 1994). Theophylline has also 
been found to have anti-inflammatory effects, which are at least partly mediated 
by histone deacetylase (HDAC). The stimulation of HDAC activity was not 
observed with specific PDE inhibitors or adenosine receptor antagonists (Ito et 
al., 2002). This also indicates that there are additional targets for theophylline, 
but these have not been identified. 
 In humans, theophylline is metabolized in the liver by cytochrome P450 
(CYP) enzymes 1A1, 1A2, 2D6 and 2E1 (Ha et al., 1995). The major metabolites 
are 1,3-dimethyluric acid (DMU), 3-methylxanthine (3-MX) and 1-methyl-uric acid 
(1-MU). It is excreted in the urine as 16.6 ± 6.5% unchanged theophylline, while 
DMU, 1-MU and 3-MX account for 44.3 ± 7.0%, 24.3 ± 4.8% and 12.9 ± 3.4% 
respectively (Gundert-Remy et al., 1983).  
 Cellular uptake of theophylline is facilitated by the organic human anion 
transporter 2 (hOat2). The intracellular concentration of theophylline in Xenopus 
laevis oocyes was increased by 5.9-fold by the expression of hOat2 after a 48 
hour incubation. The uptake follows Michaelis-Menten kinetics, and the Km for 
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theophylline is 12.6 µM (Kobayashi et al., 2005). Oat2 is expressed mainly in the 
liver and kidney (Sun et al., 2001).  
 Theophylline can cross the blood brain barrier, and reaches a maximum 
concentration 20-30 min after intravenous injection of 10 or 30 mg/kg. The 
distribution was not affected when p-glycoprotein was inhibited by administration 
of 10 mg/kg cyclosporine (Tsai and Liu, 2004). The ratio of total concentration in 
brain to plasma is 0.31 at steady state. The unbound fraction of theophylline in 
plasma and brain are 0.29 and 0.31 respectively (Becker and Liu, 2006). 
The theophylline aptamer 
An RNA aptamer that binds 
theophylline was selected by 
a modified SELEX procedure. 
Five rounds of regular 
selection were performed by 
capturing the RNA on a 
sepharose column to which 
was linked 1-carboxypropyl 
theophylline, followed by 
elution with 0.1 M 
theophylline. Another three 
rounds were performed where 
an additional step (counter-
Figure 1.1. A: Chemical structure of 
theophylline and caffeine. B: Secondary 
structure of the 33 nucleotide truncated 
theophylline aptamer (Zimmermann et al., 
2000) 
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SELEX) was included to select against any RNA that could bind the structurally 
similar caffeine (Fig. 1.1A). In these steps the column with bound RNA was 
washed with 0.1 M caffeine before elution with theophylline. The resulting pool 
was cloned and 16 sequences were found to contain 15 conserved bases. A 42 
nucleotide aptamer (TCT8-4) containing the conserved sequence was found to 
have high affinity for theophylline Kd (dissociation constant) of 0.32 µM, which 
was 10000-fold higher than for caffeine (Jenison et al., 1994). 
A smaller 33 nucleotide form of the theophylline aptamer (Fig. 1.1B) was 
made by truncating the terminal stem and replacing the original loop with a more 
stable GAAA tetraloop. NMR spectroscopy of a complex of this aptamer with 
theophylline reveals that the theophylline is stacked in between bases in the 
aptamer and forms hydrogen bonds with a cytosine and a uracil. The cytosine 
interacts with a hydrogen atom at nitrogen 7 in theophylline, which is replaced by 
a methyl group in caffeine (Zimmermann et al., 1997). High affinity binding 
requires 5 mM Mg2+, Mn2+ or Co2+, and a metal binding site was found in the 
theophylline binding pocket of the aptamer. The binding pocket that forms around 
theophylline is not created in the presence of caffeine, which only shows stacking 
interactions with the terminal base pair of the aptamer (Zimmermann et al., 
2000). 
A fluorescent sensor that can detect theophylline at a concentration of 
1-4 µM, was assembled by combining the theophylline aptamer with hybridizing 
DNA probes labeled with fluorophore and quenchers (Rankin et al., 2006). The 
theophylline aptamer was also used to make the first electrochemical sensor 
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based on an RNA aptamer. This sensor has a dynamic range of 200 nM to 
10 µM of theophylline, and shows no interference from 1 mM caffeine 
(Ferapontova et al., 2008). 
The theophylline aptamer has been used to make several artificial RNA 
constructs that change conformation in response to theophylline, and can be 
used to regulate various intracellular processes in bacteria, yeast and cultured 
human cells. An artificial riboswitch was inserted into an mRNA to regulate 
translation in Bacillus subtilis.  Theophylline (6 mM) was used to induce switching 
between different stem loop structures adjacent to the ribosomal binding site of 
the mRNA, which in turn reduces the level of translation of the mRNA construct 
by 8-fold (Suess et al., 2004).  
Another group applied the theophylline aptamer to make various trans-
acting regulatory modules (riboregulators). The riboregulators were tested for 
their ability to reversibly bind to a target mRNA and inhibit translation in yeast 
(Saccharomyces cereviciae). These riboregulators contain an antisense 
sequence that is complementary to a target mRNA, another sequence that can 
bind and sequester the antisense sequence, and an RNA aptamer that responds 
to a target molecule with a conformational change. The antisense sequence is 
sequestered in the free RNA and released by binding of theophylline to its 
aptamer. The most sensitive construct inhibits translation at a theophylline 
concentration around 100 µM (Bayer and Smolke, 2005).  
Aptamer controlled regulation of RNAi (RNA interference) in HEK 293 
(human embryonic kidney) cells was also demonstrated using the theophylline 
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aptamer. Short hairpin RNAs (shRNAs) were constructed with the loop region 
replaced by the theophylline aptamer. Theophylline was used to regulate shRNA 
processing by DICER and consequently RNAi activity. Inhibition of RNAi was 
observed first with 100 µM and increased with theophylline concentration up to 
10 mM (An et al., 2006).  
The IMAGEtag reporter system 
The proposed IMAGEtag (intracellular multi aptamer genetic tag) will consist of a 
string of multiple tandem aptamers that can be expressed in the cells as RNA. 
The IMAGEtag will not encode any protein, but could be used to make fusion 
construct with endogenous mRNAs so that these can be localized and tracked in 
the cell. Detection of the IMAGEtags relies on the aptamers’ binding to a ligand 
molecule that is labeled with a fluorescent moiety or radioactive element, which 
would be added to the cells before analysis. To increase the binding capacity and 
the potential signal of such tags, constructs with several aptamers have been 
created by employing a cloning technique based on methods previously used for 
creating repetitive polypeptides (Meyer and Chilkoti, 2002; Won and Barron, 
2002).  
Collaborator contributions 
The cloning method presented in Chapter 2 was developed by me based 
on previously published methods (Meyer and Chilkoti, 2002; Won and Barron, 
2002) and utilized by me and my colleagues to clone other multiaptamer 
constructs as part of the Nilsen-Hamilton laboratory IMAGEtag project. Relevant 
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data generated from these collaborations is included in Chapter 2 of this thesis. 
Tobramycin multiaptamers were prepared by Ilchung Shin, and neomycin, 
kanamycin and alternating neomycin-tobramycin multiaptamers were created by 
Muslum Ilgu. 
GK38, a conjugate of theophylline and Rhodamine-B utilized for several 
experiments presented in chapter 3, was synthesized by the graduate research 
assistant Vinayak Gupta in the lab of Dr. George Kraus (Department of 
Chemistry, Iowa State University). 
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CHAPTER 2.  CLONING OF MULTIPLE TANDEM REPEATS OF 
PROTEIN DOMAINS AND APTAMERS  
A manuscript prepared for submission to the journal BioTechniques 
Hans Eirik Haarberg, Muslum Ilgu, Ilchung Shin, Marit Nilsen-Hamilton 
Abstract 
Constructing and cloning repetitive DNA sequences can be a technical 
challenge.  Yet, tandemly repeated sequences have been employed to increase 
the binding capacities of DNA segments and protein domains and have 
applications in studies of the structure and function of nucleic acids and protein 
polymers. The recursive directional ligation and PCR-based methods of 
assembling DNA repetitive sequences that have been developed to date have 
limited application because they are technically complex, time consuming, cost 
inefficient, and/or specifically designed for each DNA sequence to be multiplied. 
Here we describe a simplified method for efficiently and cost effectively 
generating tandem repeats of a variety of sequences and lengths of DNA that 
can be used without modification for each application.  Whereas other reported 
methods for generating repeated DNA sequences require significant modification 
to generate tandem repeats of different sequences of interest, our method is 
broadly applicable, without modification, to most DNA sequences. In this method, 
the restriction enzymes BsmAI and BsaI are utilized to generate tandem repeats 
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of a variety of DNA sequences.  Here we give examples of the generation of 
repeated aptamer and polypeptide sequences.  
Introduction 
There has been an interest in generation of tandem repetitive DNA sequences 
for several applications.  Repetitive sequences have been used to study the 
structure and function of DNA (Tchernaenko et al., 2003). Tandem repeats of 
transcriptional regulatory elements have been used in affinity chromatography for 
purification of DNA binding proteins (Kadonaga and Tjian, 1986) and to study the 
activity of transcription factors (Veldman et al., 1985; Schafer and Fournier, 
1992).  Other DNA constructs have been prepared for expressing repetitive 
protein domains. Tandem repeats have been used to study functional protein 
domains such as the Ras-binding domain of C-Raf (Augsten et al., 2006).  Many 
synthetic repetitive polypeptides have properties similar to natural proteins such 
as extracellular matrix proteins (Welsh and Tirrell, 2000) and spider web proteins 
(Zhou et al., 2001).  An increase in a need for repetitive polypeptides, to be used 
as components of the extracellular matrix, is expected with further advances in 
tissue replacement therapy (Kim and Mooney, 1998). 
To make constructs for expressing repetitive polypeptide sequences, 
Meyer and Chilkoti developed the recursive directional ligation (RDL) technique 
(Meyer and Chilkoti, 2002). RDL allows a fragment contained in a plasmid within 
two selected restriction enzyme sites to be multiplied to create longer repetitive 
sequences, and can be repeated to generate constructs of increasing length. The 
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method utilizes restriction enzymes with split palindromic recognition sequences. 
This makes it possible to perform seamless multiplication of a fragment by 
excising the fragment with both enzymes, and ligating it back into the same 
vector that has been digested with only one of these enzymes. However, with 
this method, part of the recognition sequence of each enzyme is within the 
sequence that is being multiplied. Consequently, different restriction enzymes 
must be used for multiplying different sequences. 
Won and Barron developed a method for making repetitive sequences that 
encoded polypeptides, without DNA sequence restrictions, using a pair of 
type IIS restriction enzymes that cleave the DNA at one side of a recognition 
sequence that is asymmetrical (Won and Barron, 2002).  However, the strategy 
required PCR and numerous enzymatic reactions. 
Our modified RDL technique utilizes two non palindromic restriction 
enzymes, BsaI and BsmAI, to make constructs with repetitive sequences.  The 
method is time-efficient, reliable and can be used for most DNA sequences 
without adjustments.  Following this modified RDL method, we created DNA 
sequences encoding a protein with repeats of the 25 amino acid C-terminal 
domain of the bacterial magnetosome forming protein Mms6 (Arakaki et al., 
2003), and RNAs consisting of multiple copies of the aptamers for theophylline 
(Jenison et al., 1994), tobramycin (Jiang et al., 1997), kanamycin (Werstuck and 
Green, 1998) and neomycin (Jiang et al., 1999). 
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Materials and Methods 
Materials 
The cloning vector pZErO-2 and Vector NTI Software were from Invitrogen 
(Carlsbad, CA, USA).  E. coli strain NEB 5-alpha and restriction endonucleases 
AflIII, ApoI, BsaI and BsmAI were obtained from New England Biolabs (Ipswich, 
MA, USA).  Calf intestinal alkaline phosphatase (CIAP), T4 polynucleotide kinase 
and T4 DNA ligase were purchased from Promega (Madison, WI, USA).  
QIAquick Gel Extraction Kit and QIAprep Spin Miniprep Kit were obtained from 
QIAgen (Valencia, CA, USA).  Sequencing primers 2819 (5’-GGCCT TTTTA 
CGGTT CCTGG-3’) and 2820 (5’-GCCGC TCCCG ATTCG CAG-3’), and all 
oligonucleotides used to make inserts were synthesized by the Iowa State 
University DNA Facility (DSSF).  All sequencing was done by the DSSF. 
Cloning of initial repetitive sequences from synthetic oligonucleotides 
The vector for cloning the repetitive sequences was created by digesting the 
pZErO-2 vector with restriction enzymes AflIII and ApoI. The fragment of 1854 
base pairs was isolated using gel electrophoresis, and purified with QIAquick gel 
extraction kit. Two pairs of complementary oligonucleotides were used to create 
inserts containing between two and seven repeats (150-250bp) of the monomer 
sequences (Table 1), flanked by restriction sites for BsaI and BsmAI for 
subsequent multiplication. Complementary oligonucleotides were annealed by 
slow cooling from 95°C to 25°C and phosphorylated usin g the T4 polynucleotide 
kinase. The double stranded inserts were cloned into the vector with T4 DNA 
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ligase and transformed into E. coli strain NEB 5-alpha by heat shock (1 min, 
42°C). 
Construction of longer repetitive sequences 
The initial repetitive sequences were cut out of the vector using BsmAI, and 
purified using agarose gel electrophoresis.  A separate fraction of the vector was 
cut with BsaI, which cuts at a single site at the 5’ end of the multiaptamer, leaving 
the aptamers in the vector.  The BsaI digested vector was then dephosphory-
lated, and the multiaptamer fragment that had been excised with BsmAI was 
cloned into the dephosphorylated vector (Fig. 2.1).  Clones were analyzed for 
insertions by digestion with BsmAI, and sequenced in each direction with primers 
2819 and 2820. 
Results and Discussion 
Repetitive aptamer sequences constructed using oligonucleotides 
Digestion of the pZErO-2 vector with AflIII and ApoI removed parts of the original 
pZErO-2 vector that was considered unnecessary for the purpose of this cloning 
method.  Oligonucleotides were used to create five repeats of the theophylline 
aptamer.  Analysis of eight clones was done by digestion with BsmAI followed by 
agarose gel electrophoresis.  Four constructs appeared to have an insert, but the 
sizes were different and only one appeared to have five repeats as expected. 
Sequencing showed that the clones contained 3, 4, 5 and 6 aptamer repeats. 
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Plasmid pHEH14 (Fig. 2.2) containing 6 repeats of the theophylline aptamer was 
used for further multiplication to make longer repeating sequences. 
Multiplication of the original repetitive sequences 
The multiplication of aptamer sequence repeats was achieved by utilizing the 
restriction enzymes BsaI and BsmAI.  These restriction enzymes are unusual 
because their recognition sequences are not palindromic, and the restriction 
enzymes cut the DNA outside of their recognition sequence.  Consequently, the 
restriction enzyme sites remain unaltered after digestion, and four-base 
overhangs are created from the adjacent base pairs. The sequence between the 
restriction sites is designed so that four of the bases at either end of the fragment 
are repeated at the other end in order to create compatible overhangs after 
digestion (Fig. 2.2). Additionally, the recognition sequence for BsmAI is also 
present within the sequence for BsaI, so that any sequence cut by BsaI is also 
cut by BsmAI but not vice versa. With this construct, the fragment between the 
two restriction enzyme sites can be cut out from the vector with BsmAI, while 
digestion with BsaI only cuts the vector open at one end of the fragment. The 
fragment that was cut out with BsmAI can be ligated back into the same vector 
but that has been digested with BsaI, resulting in multiplication of the number of 
repeats. 
This procedure was first used to multiply the 6 repeats of the theophylline 
aptamers in vector pHEH14.  Twenty colonies were prepared and analyzed by 
digestion with BsmAI and agarose gel electrophoresis (Fig. 2.3).  From the sizes 
 30 
of the fragments, 14 of the 20 clones appeared to have 12 repeats (Size 444bp) 
of the aptamer. One of these clones was sequenced and the presence of 12 
aptamers was confirmed. One clone had a larger fragment, and was found by 
sequencing to contain 18 repeats. Two clones had smaller fragments, one of 
which was sequenced and determined to contain 9 repeats. The constructs with 
12 and 18 repeats were expected, and result from incorporation of one or two 6-
aptamer fragments respectively. The presence of 9 repeats can only have 
resulted if several aptamer sequences were removed from the construct during 
cloning. pHEH15 containing 18 repeats was the longest repetitive sequence 
obtained and this clone was used in the next round of multiplication. 
 The same method was used in the second round of cloning to multiply the 
18 repeats contained in vector pHEH15. The result was three clones with 
fragments of sizes corresponding to approximately 270, 108 and 90 repeats 
(Fig. 2.4).  These sizes correspond to 15, 6 and 5 fragments of the original 18 
repeats respectively. The fourth clone appears to have two different fragments 
and possibly contains two distinct constructs.  
The exact number of aptamers in these constructs is hard to determine 
from the estimated size of the fragments on the gel.  Sequences of the clones 
from each side of the construct confirmed the correct sequence of the adjacent 
restriction sites and approximately 30 repeats of the multiaptamers at each end. 
Sequencing was however limited to about 1000-1200 bases, which corresponds 
to approximately 30 aptamers.  Because the same sequence is repeated 
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throughout the construct it is impossible to design any unique primers for 
sequencing within the fragment. 
Other repetitive constructs 
Including the cloning of theophylline multiaptamers, this method was used 
to make similar constructs of other sequences. The technique has proven 
successful for cloning multiple repeats of the sequence of aptamers for 
kanamycin, neomycin and tobramycin, as well as a sequence encoding the 25 
amino acid C-terminus of the Mms6 protein (Table 2).  
Stability of repetitive constructs 
Secondary structure of DNA, particularly in the form of direct repeats and 
palindromic sequences, can destabilize the DNA during replication and result in 
deletions, insertions and rearrangements (Bi and Liu, 1994; Rosche et al., 1995; 
Bi and Liu, 1996). This feature of bacterial DNA synthesis and repair is probably 
the basis of the recurrent observations with several aptamer constructs that the 
number of repeats obtained did not match a multiple of the number of repeats in 
the fragments used for the cloning.  In the case of the theophylline, tobramycin, 
neomycin and kanamycin aptamers, the clones obtained always included 
complete aptamer sequences with no partial aptamer sequences.  This result 
might be due to the strong secondary stem loop structures of these aptamers 
that probably result in the formation of cruciform DNA and recombination or DNA 
repair involving breakage at one or the other side of the cruciform. Except for the 
longest repeated sequence (270 tandem theophylline aptamers) all other stem-
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loop aptamer structures cloned by this method were stable as demonstrated by 
successful cloning of the repetitive sequences into other vectors. The correct 
number of repeats were confirmed by restriction digestion and sequencing. 
By contrast with the theophylline and aminoglycoside aptamers, the 
tetracycline aptamer forms a more complex structure with several stems and 
loops.  Only fragments of two aptamers were obtained when cloning of 
oligonucleotide repeats of the tetracycline aptamer was attempted.  Repeats of 
the length represented by the tetracycline aptamer are deleted by a recA-
independent mechanism, which in pBR322 can be influenced by another D7 
region within the plasmid acting in cis (Bi and Liu, 1996). Thus, the stability of 
clones containing repeated sequences is restricted by the bacterial replication 
and recombination systems and the cis-acting features in the plasmid.  For this 
reason it is desirable, as we have done, to use a small (stripped down) plasmid 
for cloning the repetitive sequences so as to minimize the presence of cis-acting 
features that promote recA-independent recombination. 
Summary 
In summary, we demonstrate a method that can be used to clone 
repetitive DNA sequences of a variety of forms, some with strong internal 
structures (aptamers) and others without stable internal structures (mature Mms6 
coding sequence).  The method is time and cost-effective and results in plasmids 
containing multiple repeated sequences can be stably maintained. 
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Tables 
Table 1. Monomer sequences 
Name Sequence 
Theophylline 
aptamer* 
GGTGATACCAGCCGAAAGGCCCTTGGCAGCACC 
Tetracycline 
Aptamer* 
GGCCTAAAACATACCAGAGAAATCTGGAGAGGTGAAGAAT
ACGACCACCTAGGCC 
Mms6-C25 TACGCGTATATGAAGAGCCGTGATATCGAATCGGCGCAGA
GCGACGAGGAAGTCGAACTGCGCGACGCGCTGGCC 
Kanamycin 
aptamer* 
GCGCAGUGGGCAUAGAACCAUGCGC 
Tobramycin 
aptamer* 
GGCACGAGGUUUAGCUACACUCGUGCC 
Neomycin 
aptamer* 
GGACUGGGCGAGAAGUUUAGUCC 
* Each repeat of the multiple aptamers also contained a linker of four As. 
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Table 2. Constructs with repetitive sequences 
Sequence Source (monomer repeats) Number of repeats 
Theophylline aptamer 
Oligonucleotides (5) 3*, 4*, 5, 6* 
Vector (6)  9*, 12, 18 
Vector (18) 90, 108, 270 
mms6-C25 Oligonucleotides (2) 2 
 Vector (2) 4, 6, 8 
Tetracycline aptamer Oligonucleotides (3) 2 partial aptamers 
Tobramycin aptamer  
Oligonucleotides 5 
Vector (5)  10 
Vector (10)  14* 
Neomycin aptamer  
Oligonucleotides (6) 6, 8* 
Vector (8) 16, 23*, 24, 32 
Kanamycin aptamer  
Oligonucleotides (7) 7 
Vector (7) 9*, 12*, 14, 28 
Alternating 
Neomycin-Tobramycin 
aptamers  
Oligonucleotides (4) 4 
Vector (4) 8 
* The number of repeats obtained was not expected from the source used. 
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Legends to Figures 
Figure 2.1. Multiplication of repetitive sequences. A: The double stranded 
recognition sequences (highlighted) and location of cut sites (arrows) for BsaI 
and BsmAI. N indicates any base (A, C, G or T) B: Outline of the strategy for 
multiaptamer cloning. The cloning vector contains two recognition sequences for 
BsmAI, one on each side of the multiaptamer sequence. The multiaptamer 
sequence is cut out of the vector with BsmAI (1), and purified by agarose gel 
electrophoresis (2). One of the BsmAI sites contains an additional GC base pair 
and is recognized by BsaI, while the other site contains a TA base pair and is 
therefore protected from cleavage by BsaI. Digestion with BsaI cuts open the 
vector, while leaving the original multiaptamers in the vector (3). The digested 
vector is then dephosphorylated (4) to prevent self ligation of the vector in the 
final step. The purified multiaptamer is ligated back into the single cut vector to 
create several copies of the multiaptamer sequence (5). Several multiaptamer 
fragments can potentially be ligated into the vector. Because the restriction 
enzyme sites are unaffected, this method can be repeated to create constructs 
with increasing numbers of repeats. 
Figure 2.2. Plasmid pHEH14 containing 6 repeats of the theophylline 
aptamer. The vector contains only the origin of replication and the kanamycin 
resistance gene of the original pZErO-2 vector. Tandem repeats of the 
theophylline aptamer are flanked by the restriction sites for multiplying the 
repetitive sequence (BsaI and BsmAI), and primers 2819 and 2820 for 
sequencing from each side of the construct. 
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Figure 2.3. Agarose gel electrophoresis of clones from the first 
multiaptamer cloning.  M: DNA marker (from top: 1500, 850, 400, 200 and 
100bp). 1-20: clones digested with BsmAI. Each clone has two bands from the 
vector (840 and 1049bp), in addition to a band from the multiaptamer. Clones 1, 
4 and 13 were sequenced and determined to contain 12, 9 and 18 repeats 
respectively. 
Figure 2.4. Agarose gel electrophoresis of clones from the second 
multiaptamer cloning.  M: DNA marker (from top: 10, 8, 6, 5, 4, 3.5, 3, 2.5, 2 
and 1.5kb). 1-4: Clones digested with BsaI and ApoI. Each clone has a band 
from the vector (1872bp), and a band from the multiaptamer. Clones 1, 2 and 3 
are estimated to contain 270 (9990bp), 108 (3990bp) and 90 (3330bp) aptamer 
repeats respectively 
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CHAPTER 3. STUDY OF THE THEOPHYLLINE IMAGETAG AND 
LIGANDS 
Abstract 
An efficient RNA reporter is expected to have several significant advantages for 
studying gene expression and RNA, and several potential reporters have been 
developed utilizing RNA aptamers. However, no such reporter has been used 
successfully to study RNA expressed in living cells. The theophylline 
multiaptamer and fluorescent and radioactively labeled theophylline were studied 
in cultured CCL-64 cells in an attempt to develop a cellular RNA reporter system. 
The multiaptamer RNA was expressed from a plasmid containing the β-actin 
promoter and a cytomegalovirus (CMV) enhancer by transient transfection and 
RNA levels were determined using real time reverse transcription PCR. The 
interactions of the aptamer ligands with the cells were studied using both 
fluorescent and radioactive labeled theophylline. The theophylline multiaptamer 
RNA was expressed and shown to have high stability in the CCL-64 cells. The 
ligands successfully entered the cells, but bound to endogenous cellular 
components and over 50 percent of the ligands taken up by the cells remained 
inside the cells after one hour. The binding of ligand to the cells created a high 
background signal that was independent of aptamer expression. 
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Introduction 
A successful IMAGEtag would offer several advantages over current protein 
reporters including significant reductions in both energy requirement and 
response time, and would also allow endogenous RNAs to be tagged to 
investigate RNA localization and transport. 
Several groups have attempted to develop aptamer based RNA reporters. 
These attempts include selecting aptamers that can bind and sequester 
fluorophores form solution  (Holeman et al., 1998) and aptamers that can 
increase the fluorescence of target molecules (Babendure et al., 2003); (Sparano 
and Koide, 2007; Constantin et al., 2008; Sando et al., 2008). Although several 
candidate reporters have exhibited promising results in in vitro assays, no 
aptamer tag has so far been used successfully in vivo or in cultured cells. 
The reasons for the limitations of previous RNA reporters are not clear, 
but it is apparent that several conditions have to be satisfied for an aptamer 
based RNA tag to be successful in living cells. The strength of the signal 
depends on both the intracellular concentration of the RNA aptamer itself, and 
that a high proportion of the aptamers bind to the ligand. Thus, the aptamers 
should be efficiently transcribed, stable and have a high affinity for the ligand, 
while the ligand must efficiently traverse the cell membrane to interact with the 
aptamer. In addition, the ligand should not bind to cellular components because 
this would create a high background signal that would be present in all cells and 
compete with the specific signal from aptamer bound ligands. 
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The theophylline multiaptamer transcripts and fluorescent and radioactive 
ligands were studied in cell culture to determine if they satisfy the requirements 
for a functional IMAGEtag. The mink (Mustela vison) lung epithelial cell line 
CCL-64 from ATCC was used for all cell culture studies. This cell line has been 
used by other members of the Nilsen-Hamilton lab and was chosen for these 
experiments because of a particularly high transfection efficiency attained with 
these cells.  
The IMAGEtag RNA was expressed in CCL-64 cells from a mammalian 
expression vector containing a β-actin promoter and a cytomegalovirus (CMV) 
enhancer. The expression vector was introduced into the cells by lipofection, and 
real time reverse transcription PCR was utilized to determine the level of 
IMAGEtag RNA present in the cells. Time course studies of RNA were performed 
to determine the time of maximal expression and the stability of the RNA. 
 The cellular uptake, efflux and retention were investigated for both 
fluorescent and radioactive labeled theophylline. Additionally, the location of the 
fluorescent labeled theophylline was determined using fluorescent confocal 
microscopy. 
Materials and Methods 
Plasmids and Reagents 
The expression vector with CMV enhancer and β-actin promoter: pKS35-CMV-
UTC was obtained from C. Tuggle, Department of Animal Science, Iowa State 
University).  The expression vector with eGFP (enhanced green fluorescent 
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protein): peGFP was purchased from Clontech (Palo Alto, CA). SalI and DNase 
(RNase free) were from New England Biolabs (Ipswich, MA). HindIII, T4 
polynucleotide kinase and T4 DNA ligase were from Promega (Madison, WI). 
Cordycepin, DMEM (high glucose), rhodamine-B base, theophylline, 
theophylline-[8-3H], Nonidet P-40 substitute and Hoechst 33250 were from 
Sigma-Aldrich (St. Louis, MO). Penicillin-streptomycin was from Gibco BRL 
(Grand Island, NY). YO-PRO-1, lipofectamine 2000 and TRIzol reagent were 
from Invitrogen (Carlsbad, CA). Full Velocity and Brilliant II qRT-PCR kits were 
from Stratagene (La Jolla, CA). HEPES (enzyme grade) and Scintiverse BD 
Cocktail were from Fisher Scientific (Pittsburgh, PA). Agarose was from ISC 
BioExpress (Kaysville, UT). Bovine calf serum was from Hyclone (Logan, UT). 
NanoDrop-1000 spectrophotometer was from NanoDrop Technologies 
(Wilmington, DE). All sequencing was done by the Iowa State University DNA 
Facility (DSSF). The following oligonucleotides for use as primers or inserts were 
synthesized by the DSSF: 144 (5’-CCAAC CGACT GCTGT CAC-3’), 224 (5’-
GCTTA ATACG ACTCA CTATA GGGCG GCTAT TCTCG CAGGA-3’), 1902 
(5’-AATGC CAGCC CCAGC ATCGA AG-3’), 1905 (5’-CCCAC CCCCA ATGTG 
TCTGT-3’), 2823 (5’-TCGAG CGGCC GCTCG AGGAT CCTAA TACGA CTCAC 
TATAG GGAGA CAAGA ATACG CTCAA GTCGA CGCCG AAAAG CCGAA 
GCTTC GACAG GAGGC TCACA ACAGG CTAGC-3’), 2824 (5’-AGCTG CTAGC 
CTGTT GTGAG CCTCC TGTCG AAGCT TCGGC TTTTC GGCGT CGACT 
TGAGC GTATT CTTGT CTCCC TATAG TGAGT CGTAT TAGGA TCCTC 
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Figure 3.1. Chemical structure of GK38 
GAGCG GCCGC -3’), 2837 (5’-GGGGT GGCTT TTAGG ATGGC AA-3’), 2839 
(5’-CGACA GGAGG CTCAC AACAG GCTA-3’).  
GK38 is a conjugate of 
theophylline and Rhodamine-B 
(Fig. 3.1). The synthesis of GK38 
was performed by the graduate 
research assistant Vinayak Gupta in 
the lab of Dr. George Kraus 
(Department of Chemistry, Iowa 
State University). 
Cloning of IMAGEtags into expression vectors 
An expression vector for the insertion of theophylline and other multiaptamers 
was constructed from vector pKS35-CMV-UTC. A fragment containing lipocalin 2 
cDNA was removed from the vector by sequential digestion with SalI and HindIII 
and the vector was purified by agarose gel electrophoresis. An insert containing 
a multiple cloning site for insertion of multiaptamer constructs, flanked by primer 
binding sites, was constructed from oligonucleotides 2823 and 2824. The 
oligonucleotides were annealed to create a double stranded insert with SalI and 
HindIII overhangs. The annealed oligonucleotides were phosphorylated with T4 
polynucleotide kinase and cloned into the digested vector with T4 DNA Ligase. 
Ligation mixtures were transformed into E. coli by heat shock (42°C for 1 min), 
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and clones were sequenced with primers 144 and 224. The resulting expression 
vector was named pHEH18. 
 Vector pHEH18 was digested with HindIII, followed by precipitation with 
2-Propanol and digestion with SalI. Multiaptamer constructs were excised from 
cloning vectors pHEH15, pHEH16.3 and pHEH16.1, by sequential digestion with 
SalI and HindIII. Digested expression vector and multiaptamer fragments were 
purified by gel electrophoresis with 0.5% agarose. The vector was ligated with 
each of the multiaptamer fragments, transformed and sequenced as described 
previously.  
Assay of theophylline toxicity in CCL64 cells 
CCL64 (Mink epithelial cell line) cells were incubated in medium composed of 
90% DMEM high glucose, 10% bovine calf serum and 10 u/mL 
penicillin/streptomycin for 24 h before treatment. The medium on the cells was 
replaced with new medium with or without theophylline (2.5 µM, 10 µM, 50 µM, 
250 µM, 1 mM, 5 mM or 10 mM). After 24 h of incubation with theophylline, the 
cells were stained with YO-PRO-1 and Hoechst 33250. Staining was observed 
by fluorescent microscopy (Zeiss Axiovert 40 CLF), using DAPI and FITC filters, 
and pictures were taken with each filter.  
Expression of IMAGEtags in CCL64 cells and analysis by real time RT-PCR 
Cells were transfected with plasmids pHEH21.2 (multiaptamer) or peGFP 
(enhanced green fluorescent protein) using lipofectamine 2000. The plasmid and 
lipofectamine were diluted and combined in serum free DMEM for complex 
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formation. Transfection was performed with 2 ng/µL plasmid DNA and 4 ng/µL 
lipofectamine in DMEM, 8% bovine calf serum. No antibiotic was used during 
these experiments. 
 RNA samples were prepared by dissolving the cells using TRIzol reagent 
and pipeting up and down approximately 10 times, followed by chloroform 
extraction and 2-propanol precipitation. The RNA yield was determined with a 
NanoDrop 1000, and samples were treated with RNase free DNase. RNA was 
quantified by one-step reverse transcription real time PCR using the Full Velocity 
qRT-PCR kit. IMAGEtag transcripts were PCR amplified with primers 2837 and 
2839. The mink GAPDH gene was used as a reference, and PCR was performed 
with primers 1902 and 1905.  
Uptake and efflux of rhodamine-B and GK38 
Confluent CCL64 cells were washed and incubated for 30-40 min with Hanks 
balanced salt solution (HBSS; pH 7.4, 137 mM NaCl, 5.4 mM KCl, 1.3 mM CaCl2, 
0.5mM MgCl2, 0.6 mM MgSO4, 4.2 mM NaHCO3, 0.4 mM KH2PO4, 0.3 mM 
Na2HPO4). For measuring uptake, the cells were incubated with HBSS containing 
either rhodamine-B or GK38. After specified periods of time the dye solutions 
were removed, the cells were washed two times with HBSS, and the cells were 
harvested by scraping into lysis buffer (pH 7.2, 20 mM HEPES, 0.5% Nonidet P-
40) 
 For efflux measurement, the cells were incubated in HBSS containing 1.8 
µM of either dye (rhodamine-B or GK38) for 30 min. The cells were then rinsed 
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twice with HBSS, and incubated in HBSS for efflux of the dye. After the 
designated periods of efflux the HBSS was removed and cells were scraped into 
lysis buffer. For both uptake and efflux experiments, the amount of dye in the 
cells was determined by measuring fluorescence with a Cary Eclipse fluorometer 
(Varian). Samples were excited at 550 nm and emission was measured at 578. 
Determining the intracellular localization of GK38 by confocal microscopy 
CCL64 cells were incubated in HBSS with 10 µM GK38 at 37°C for 1 h. The cells 
were rinsed once and incubated in HBSS without GK38 for three hours before 
analysis. Confocal microscopy was performed at 60x magnification with a Nikon 
Eclipse TE200 microscope at the Roy J. Carver lab for ultrahigh resolution 
biological microscopy. GK38 was excited with a 568 nm Kr/Ar laser and 
fluorescence was detected at 580-620 nm through a TRITC filter. A stack of 29 
slices with 0.5 µm thickness was collected. 
Efflux of theophylline-[8-3H] 
CCL64 cells were grown on cover slips and incubated at 37°C for 1 h in HBSS 
with 1.1 µM tritium labeled theophylline (activity: 2 µCi/ml). The cells were then 
washed twice with HBSS, and new HBSS solution was added for the efflux of 
theophylline. Following the specified durations of efflux, the HBSS was removed 
and the cells washed once with HBSS. Cover slips were collected and put in 
scintillation vials with Scintiverse BD Cocktail. Tritium activity was measured with 
a scintillation counter for 5 min per sample. 
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Quantification of theophylline-[8-3H] in cells with and without IMAGEtags 
To determine the effect of aptamer expression on the cellular theophylline 
concentration, cells were transfected with either plasmids pHEH21.2 
(multiaptamer) or peGFP using lipofectamine 2000. Transfection was performed 
with 2 ng/µL plasmid DNA and 4 ng/µL lipofectamine in DMEM, 8% bovine calf 
serum.  
 Cells were rinsed with HBSS 24 h after transfection, and incubated with 
either 100 nM, 0.5 µM, 2 µM or 10µM theophylline (2 µCi/ml activity each). After 
incubation with radiolabeled theophylline the cells were rinsed three times with 
HBSS, and collected using lysis buffer (pH 7.2, 20 mM HEPES, 0.5% 
Nonidet P-40). The radioactivity level was determined using Scintiverse BD 
Cocktail, scintillation counter for 4 min per sample. 
Determination of the stability of IMAGEtag RNA 
Cells were transfected with multiaptamer plasmid pHEH21.2 using lipofectamine 
2000 (Invitrogen). Plasmid and lipofectamine were diluted and combined in 
serum-free DMEM for complex formation. Transfection was performed with 
2 ng/µL plasmid DNA and 4 ng/µL lipofectamine in 92% DMEM supplemented 
with 8% bovine calf serum. 
 RNA synthesis was inhibited with 50 µg/µL cordycepin 36 h after 
transfection. The initial RNA sample (time 0) was collected 30 min after addition 
of cordycepin. Cells were collected with TRIzol reagent, followed by chloroform 
extraction and 2-propanol precipitation. RNA yield was determined with a 
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NanoDrop 2000 (Thermo Scientific), and samples were treated with RNase free 
DNase. RNA was quantified by one-step reverse transcription RT PCR using 
BrilliantII qRT-PCR kit. IMAGEtag transcripts were PCR amplified with primers 
2837 and 2839. The mink GAPDH gene was amplified for comparison with 
primers 1902 and 1905. 
Results and Discussion 
Cloning of IMAGEtags into expression vector 
Two successful multiaptamer expression vectors were created. Vector pHEH21.2 
was produced from the multiaptamer fragment of pHEH15, and contained 18 
repeats of the theophylline aptamer. Vector pHEH21.5 was cloned from the 
pHEH16.3 containing about 90 repeats. The third cloning vector used 
(pHEH16.1) was expected to contain 270 repeats, since the original cloning 
produced a fragment of ~10kb (Chapter 2). However, digestion with SalI and 
HindIII produced a fragment with a size of approximately 1kb. This fragment was 
also purified and ligated with the expression vector, but no colonies were 
produced after transformation. 
Toxicity of theophylline in CCL64 cells 
The toxicity of theophylline in CCL64 cells was investigated using the blue 
fluorescent dye YO-PRO-1. Apoptotic cells become permeable to YO-PRO-1, 
while normal cells do not. Due to this property, YO-PRO-1 selectively stains the 
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nucleus of apoptotic cells (Idziorek et al., 1995). The cells were also stained with 
Hoechst-33250, which stains the nuclei of all cells.  
The cells were incubated 
in their regular medium 
with theophylline concen-
trations of 2.5 µM, 10 µM, 
50 µM, 250 µM, 1 mM, 5 
mM and 10 mM for 24 
hours before assay with 
YO-PRO-1 and Hoechst-
33250. No cells were 
stained by YO-PRO-1 
even at the highest 
theophylline concentrat-
ions (Fig. 3.2). 
It was not expected that 
theophylline would be 
toxic at the normal 
therapeutic plasma 
concentration range of 55-110 µM (Barnes and Pauwels, 1994), and the results 
from this experiment indicate that theophylline is not toxic to CCL64 cells at 
concentrations up to 10mM. 
Figure 3.2. Pictures of cells stained with Hoechst-
33250 and YO-PRO-1 after incubation with or 
without theophylline for 24 h 
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Expression of IMAGEtags in CCL64 cells 
The amount of transcribed IMAGEtag RNA in the cells after transient transfection 
was determined by reverse transcription and real time PCR. Transcription of the 
IMAGEtag RNA (18 tandem theophylline aptamers) begins within one hour of 
transfection with the expression vector pHEH21.2. The level of IMAGEtag 
transcripts is relatively low until 12 h, but increases exponentially until 24 h after 
transfection (Fig. 3.3).  
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The RNA reaches a maximum level approximately 24 h after transfection. There 
is a rapid increase in IMAGEtag RNA level from 12 to 24 h, followed by a steady 
decrease from 24 to 72 h (Fig. 3.4). 
Figure 3.3. Relative amount of IMAGE-tag RNA in CCL64 cells from 2 to 
24 h after transfection with IMAGE-tag (18 repeat theophylline aptamer) 
expression vector pHEH21.2. Average of three samples with standard 
deviation error bars. 
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Uptake and efflux of rhodamine-B and GK38 
To test the time course of the uptake of the dyes, GK38 and rhodamine-B, 
confluent CCL64 cells were incubated with the dye for 10 to 50 minutes. After 
incubation, the cells were washed three times to remove extracellular dye, prior 
to cell collection with lysis buffer. To determine the amount of dye present in the 
cells, the fluorescence of the lysis buffer was measured. Both dyes enter the 
cells rapidly and both GK38 and rhodamine-B reach a steady intracellular level 
within 10 to 15 minutes (Fig. 3.5).  
Figure 3.4. Relative amount of IMAGE-tag RNA in CCL64 cells from 
30 min to 72 h after transfection with IMAGE-tag expression vector 
pHEH21. Average of three samples with standard deviation error bars. 
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The efflux of GK38 from CCL64 cells was investigated by incubating the cells 
with GK38 for 30 minutes, washing three times, and incubating in buffer without 
dye for 10 to 60 min. The amount of dye remaining in the cells was determined 
by measuring the fluorescence of the lysed cells at 578 nm emission; 550 nm 
excitation. GK38 decreased to 60-70% at 20 minutes and started to level off after 
this.  At 60 minutes, the fluorescence was just below 60% and it is likely that a 
majority of the dye would remain in the cell for several hours (Fig. 3.6).  
In a comparison of rhodamine-B and GK38, rhodamine-B had a slightly 
higher rate of efflux than GK38. After 1 h, the fluorescence of GK38 was 
decreased to 55-60%, while the fluorescence of Rhodamine-B was decreased to 
30- 40%. GK38 efflux also appeared to slow down after 20-30 min, while the 
efflux of rhodamine-B was nearly linear during the 60 minutes (Fig. 3.7). 
Figure 3.5. Fluorescence of lysed cells collected after incubation for 
different durations of time with either GK38 or rhodamine-B. Average of 
two samples with standard deviation error bars. 
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Efflux of Rhodamine-B and GK38
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Figure 3.6. Fluorescence of GK38 remaining in cells after incubation in 
buffer without dye for 10 to 60 minutes. Average of three samples with 
standard deviation error bars. 
 
Figure 3.7. Comparison of rhodamine-B and GK38 remaining in cells after 
0, 30 and 60 minutes of efflux. Averages of three samples with standard 
deviation error bars. 
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A significant difference between the two compounds was found when 
comparing the fluorescence of the cell lysates and the solutions of HBSS with 
either dye in which the cells were incubated. The HBSS solutions were diluted 
1:10 in lysis buffer and the fluorescence of these were measured along with the 
cell lysates. While the fluorescence of the HBSS solution with Rhodamine-B was 
almost twice as high as HBSS with GK38, the fluorescence of the lysates with 
Rhodamine-B were only a third of those with GK38. Thus GK38 was taken up by 
the cells at a 6-fold higher ratio than Rhodamine-B, when compared to the 
extracellular concentrations.  
Cellular localization of GK 38 
The conclusion from the efflux experiments was that a large fraction of the GK38 
taken up by the cells remained associated with the cells. Therefore, confocal 
microscopy was utilized to determine its cellular location. GK38 was found 
localized within the cell with the highest concentration being in one area outside 
of the nucleus; possibly the Golgi apparatus. Pictures were obtained 3 h after 
removal of GK38, at which time the fluorescence was still high (Fig. 3.8).  
Efflux of theophylline-[8-3H] 
The efflux rate for theophylline was investigated using the method employed for 
rhodamine-B and GK38, with the exception that quantification was done using 
scintillation counting instead of fluorescence measurements. The rate of 
theophylline efflux was found to be similar to that of GK38 and rhodamine-B, 
although a larger fraction of theophylline remained in the cells than for the other 
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two compounds. About 60-80% of the theophylline remained in the cells after 1 h 
(Fig. 3.9). This may also explain why more of the GK38 remains in the cell 
compared Rhodamine-B, being driven by theophylline. 
 
 
 
 
Figure 3.8. Fluorescence microscopy of GK38 at four vertical layers of 
CCL64 cells (excitation with 568 nm Kr/Ar laser and TRITC emission filter) 
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Effect of IMAGEtags on the intracellular concentration of 
theophylline-[8-3H] 
CCL64 cells transformed with either pHEH21.2 (IMAGEtag) or peGFP were 
incubated with different concentrations of theophylline to determine if expression 
of the theophylline IMAGEtag affected the concentration of theophylline inside of 
the cells. There was no significant difference between the level of theophylline in 
cells expressing the theophylline multiaptamer or eGFP (Fig. 3.10). This could be 
because the amount of theophylline binding to endogenous cell components is 
too high compared to the amount of aptamers expressed. It is also possible that 
the aptamers were not capable of binding theophylline. 
Figure 3.9. Amount of tritium labeled theophylline remaining in cells after 
removal of extracellular theophylline. Average of three samples with 
standard deviation error bars. 
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Stability and half-life of the IMAGEtag RNA in CLL64 cells 
The half life of the IMAGEtag RNA was estimated by measuring the amount of 
IMAGEtag in the cells at three time points (with 24 h intervals) after inhibition of 
mRNA synthesis by cordycepin. The rate of IMAGEtag decay was slow and 
slightly more than half of the RNA was degraded by 48 h (Fig. 3.11). An 
exponential trendline was fitted to the data points, and the equation of the 
trendline was used to calculate a half-life of 43.3 h.                                                 
Figure 3.10. Comparison of the amount of theophylline in cells expressing 
the IMAGE-tag and cells expressing eGFP. Average of three samples with 
standard deviation error bars. 
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Figure 3.11. Decay of IMAGEtag RNA in CCL64 cells after inhibition of 
transcription. Average of six samples with standard deviation error bars. 
An exponential trendline is fitted to the data points, and the equation and 
R2 for the trendline is displayed in the upper right corner.  
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CHAPTER 4. CONCLUSIONS AND FUTURE DIRECTIONS 
The proposed RNA reporter system may offer several advantages over 
current protein reporters, such as a significant reduction in energy consumption. 
This system also has the potential to detect rapid changes in gene expression 
because the time required to transcribe RNA is minimal compared to the time 
required for translation and maturation of fluorescent proteins, which are 
currently being used as promoter reporters. The RNA reporter could also be used 
as a tag to track RNA, analogous to the way fluorescent proteins have been used 
to tag proteins. However, because many protein molecules are produced from 
each RNA molecule, there is normally an amplification of a signal from RNA to 
protein. Because this amplification is lost when RNA is used as a reporter, it is 
important to consider ways to maximize the signal that can be produced by an 
RNA reporter. To increase the capacity of the RNA reporter to bind numerous 
labeled ligands, multiaptamers were constructed. 
The modified version of the recursive directional ligation technique was 
successfully used to make several multiaptamer constructs of different lengths. 
Six repeats of the theophylline aptamer constructed from synthetic 
oligonucleotides were multiplied to create 18 repeats. The 18 repeat construct 
was then used to create constructs with 90 and 270 repeats of the theophylline 
aptamer. Following this method, other researchers in the Nilsen-Hamilton lab 
have created similar multiaptamer constructs of different lengths from the 
kanamycin, tobramycin and neomycin aptamers. The method of recursive 
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directional ligation utilized here is novel in its application to multiaptamer 
construction. As opposed to the original method, the restriction enzymes 
employed here can be applied for multiplication of any sequence. 
The multiaptamer was cloned into an expression vector with a β-actin 
promoter and CMV enhancer. This vector was then introduced into CCL64 cells 
by transient transfection, and resulted in successful expression of the 
multiaptamer RNA. The expression begins within a few hours after transfection, 
with the highest rate of expression from 12 to 24 h after transfection. The quantity 
of RNA reached a maximum level around 24 h, followed by a slow and steady 
decrease. The multiaptamer RNA is quite stable, with a half life of approximately 
43 h.  
In order for an aptamer to be useful as either a genetic reporter or RNA-
tag, it must be able to generate an unambiguous signal. This could be achieved 
in two ways: first, by inducing a fluorescent signal in a ligand that has low 
fluorescence by itself, or second, by sequestering a ligand that is either 
fluorescent or labeled with a radioisotope. Because theophylline has no inducible 
fluorescence, the aptamer must be able to efficiently sequester a labeled 
theophylline. Our results do not indicate that there is any difference in the level of 
tritium labeled theophylline taken up by cells transfected with the theophylline 
multiaptamer or another vector. It is possible that the aptamer was not functional 
because of the structure of the RNA transcript, or due to interactions with other 
components in the intracellular environment. 
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Another obstacle to using the theophylline aptamer in an IMAGEtag is 
evident from the results of efflux studies of theophylline, rhodamine-B and the 
theophylline-rhodamine-B conjugate GK38. It appears that all three compounds 
bind to endogenous cell components, because a significant amount remains in 
the cells after 1 h. This creates a high background signal in all cells. For GK38, 
about 55-60% of the compound is still present in the cells after 1 h. Fluorescent 
imaging by confocal microscopy revealed that the GK38 retained by the cell is 
localized to cytoplasm, with high concentrations in one area adjacent to the 
nucleus (possibly in the Golgi apparatus). The intracellular binding of GK38 could 
be caused by the theophylline segment of the molecule, the rhodamine-B 
segment of the molecule, or a combination of both. Efflux studies of rhodamine-B 
and theophylline revealed that 30-40% of rhodamine-B and 60-80% of 
theophylline remained in the cells after 1 h. Thus the binding property of GK38 is 
intermediate of its two molecular components. Although rhodamine-B could be 
exchanged for another fluorescent label, it is unlikely to cause a significant 
reduction in binding because theophylline appears to be a larger contributor to 
the cellular binding. This could limit the effectiveness of using theophylline and 
the theophylline aptamer in developing a reporter system. 
A possible solution to the high background binding may be to utilize 
Förster resonance energy transfer (FRET) (Förster, 1948). In FRET studies, a 
donor fluorophore is excited by an external source, but instead of emitting a 
photon, the absorbed energy is transferred to an acceptor fluorophore. To 
achieve efficient FRET the two fluorophores have to be compatible so that the 
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emission spectrum of the donor overlaps with the excitation spectrum of the 
acceptor. Another requirement for FRET is that the donor and acceptor 
molecules are in close proximity (1-10nm). For this reason, FRET is often used to 
determine conformational changes and associations between labeled molecules. 
In regard to the multiaptamers, a pair of FRET compatible aptamer ligands could 
be used to differentiate between ligands bound to the multiaptamers, and ligands 
bound to endogenous cell component. Due to the proximity requirement, ligands 
binding to adjacent aptamers in a multiaptamer transcript would be close enough 
for FRET to occur. Ligands that bind to other cellular components however, 
would be dispersed in a much larger volume and a very small fraction would be 
close enough to engage in FRET. 
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